FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Eris Lifesciences IPO and S Chand and Company IPO.
Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while S Chand and Company IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Eris Lifesciences IPO | S Chand and Company IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited Citigroup Global Markets India Private Limited Credit Suisse Securities (India) Private Limited |
Axis Bank Limited Credit Suisse Securities (India) Private Limited Jm Financial Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the S Chand and Company IPO is up to ₹728.56 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of S Chand and Company IPO is ₹670.00 per share.
Eris Lifesciences IPO | S Chand and Company IPO | |
---|---|---|
Face Value | ₹1 per share | ₹5 per share |
Issue Price (Lower) | ₹600.00 per share | ₹660.00 per share |
Issue Price (Upper) | ₹603.00 per share | ₹670.00 per share |
Issue Price (Final) | ₹603.00 per share | ₹670.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹60.00 per share | |
Market Lot Size | 24 shares | 22 shares |
Fresh Issue Size | 48,50,746 shares | |
Fresh Issue Size (Amount) | up to ₹325.00 Cr | |
OFS Issue Size | 2,88,75,000 shares | 60,23,236 shares |
OFS Issue Size (Amount) | up to ₹403.56 Cr | |
Issue Size Total | 2,88,75,000 shares | 1,08,73,982 shares |
Issue Size Total (Amount) | up to ₹1,741.16 Cr | up to ₹728.56 Cr |
Eris Lifesciences IPO opens on Jun 16, 2017, while S Chand and Company IPO opens on Apr 26, 2017. The closing date of Eris Lifesciences IPO and S Chand and Company IPO is Jun 20, 2017, and Apr 28, 2017, respectively.
Eris Lifesciences IPO | S Chand and Company IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jun 16, 2017 | Apr 26, 2017 |
Issue Close | Jun 20, 2017 | Apr 28, 2017 |
Basis Of Allotment (Tentative) | Jun 23, 2017 | May 04, 2017 |
Initiation of Refunds (Tentative) | Jun 27, 2017 | May 05, 2017 |
Credit of Share (Tentative) | Jun 28, 2017 | May 08, 2017 |
Listing date (Tentative) | Jun 29, 2017 | May 09, 2017 |
Anchor Lockin End date 1 | Jul 23, 2017 | Jun 03, 2017 |
Anchor Lockin End date 2 | Sep 21, 2017 | Aug 02, 2017 |
Eris Lifesciences IPO P/E ratio is , as compared to S Chand and Company IPO P/E ratio of .
Eris Lifesciences IPO | S Chand and Company IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in S Chand and Company IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and in S Chand and Company IPO.
Eris Lifesciences IPO | S Chand and Company IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 86,17,500 shares | |
NII | 43,08,750 shares | |
RII | 28,72,500 shares | |
Employee | 1,50,000 shares | |
Others | ||
Total | 1,59,48,750 shares |
Eris Lifesciences IPO subscribed 3.29x in total, whereas S Chand and Company IPO subscribed 59.49x.
Eris Lifesciences IPO | S Chand and Company IPO | |
---|---|---|
QIB (times) | 4.68x | 44.27x |
NII (times) | 0.45x | 204.65x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 3.51x | 6.07x |
Employee (times) | 0.86x | |
Other (times) | ||
Total (times) | 3.29x | 59.49x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|